Forvia soars 10% on first-half EBIT beat, affirmed outlook

Forvia (FRVIA) shares surged over 10% after its H1 2025 results showed EBIT of €722 million and net cash flow of €418 million significantly exceeding consensus, alongside in-line sales of €13.48 billion, driven by strong Electronics and Seating segments. However, the company reported a net loss of €269 million, primarily due to a €136 million impairment on its hydrogen joint venture following Stellantis's withdrawal. Forvia reiterated its full-year guidance, with analysts cautiously optimistic about its ability to manage ongoing market volatility and achieve sequential operating margin improvement in H2.

Analysis

Forvia delivered a robust operational performance in H1 2025, triggering a more than 10% share price increase. The company's sales of €13.48 billion were in line with consensus, but its EBIT of €722 million surpassed estimates by 4%, driven by strong growth in its Electronics and Seating divisions which offset weaker performance elsewhere. This resulted in an operating margin expansion of 20 basis points to 5.4%. Most notably, net cash flow reached €418 million, more than double the consensus forecast of €191 million, aided by significantly lower capital expenditures. Despite these strong operational metrics, Forvia reported a net loss of €269 million, a sharp reversal from a profit a year earlier. This loss was primarily driven by a €136 million non-cash impairment charge related to its hydrogen joint venture after partner Stellantis exited the agreement. The company has reaffirmed its full-year 2025 guidance, projecting an operating margin between 5.2% and 6.0% and a minimum net cash flow of €655 million. Analyst sentiment is cautiously optimistic, acknowledging near-term market volatility but confident in Forvia's ability to manage risks through internal measures, such as its EU-Forward savings program, which is expected to accelerate in H2.

Key Decisions for Investors

• Investors should look past the headline net loss, as it was driven by a specific non-recurring impairment, and focus on the strong underlying operational results, particularly the significant EBIT and net cash flow beats.
• The reaffirmed full-year guidance provides a stable outlook, but continued monitoring of H2 performance is crucial, especially regarding margin improvement and the company's ability to manage market volatility through its internal savings programs.
• The impairment of the hydrogen joint venture following Stellantis's exit signals a strategic setback; investors should seek clarity on Forvia's revised long-term strategy for its Clean Mobility division and the future of the associated assets.